https://news.medxy.ai/zh/transgender-breast-augmentation/Medxy AIzh2026-08-10T18:59:21-07:00跨性别女性乳房增大术：乳晕周与乳房下皱襞入路的结局比较——一项前瞻性研究 https://news.medxy.ai/ja/transgender-breast-augmentation-2/Medxy AIja2026-08-10T18:59:05-07:00トランスジェンダー女性の豊胸術：乳輪周囲切開と乳房下縁切開の転帰比較による前向き研究 https://news.medxy.ai/vi/breast-implant-comparison/Medxy AIvi2026-08-10T18:58:46-07:00Kết quả so sánh giữa đặt túi ngực qua đường quanh quầng vú và đường nếp dưới vú ở phụ nữ chuyển giới: một nghiên cứu tiền cứu https://news.medxy.ai/comparative-outcomes-of-periareolar-versus-inframammary-breast-augmentation-in-transgender-women-a-prospective-study/Medxy AIen2026-08-10T18:57:54-07:00Comparative Outcomes of Periareolar versus Inframammary Breast Augmentation in Transgender Women: A Prospective Study https://news.medxy.ai/zh/glp-1-substance-disorder/Medxy AIzh2026-08-10T18:56:25-07:00GLP-1受体激动剂或可降低酒精与物质使用障碍住院风险：来自瑞典全国性研究的启示 https://news.medxy.ai/ja/glp-1-receptor-agonists-reduce-hospital-admissions-for-alcohol-and-substance-use-disorders/Medxy AIja2026-08-10T18:56:04-07:00GLP-1受容体作動薬はアルコールおよび薬物使用障害による入院を減少させる可能性がある：スウェーデンの全国規模の調査からの知見 https://news.medxy.ai/vi/glp-1-receptor-agonists-may-reduce-hospital-admissions-for-alcohol-and-substance-use-disorders/Medxy AIvi2026-08-10T18:55:43-07:00Thuốc chủ vận thụ thể GLP-1 có thể làm giảm tỷ lệ nhập viện do rối loạn sử dụng rượu và các chất gây nghiện: Kết quả từ một nghiên cứu quy mô toàn quốc tại Thụy Điển https://news.medxy.ai/glp-1-receptor-agonists-may-reduce-hospital-admissions-for-alcohol-and-substance-use-disorders-insights-from-a-swedish-nationwide-study/Medxy AIen2026-08-10T18:54:38-07:00GLP-1 Receptor Agonists May Reduce Hospital Admissions for Alcohol and Substance Use Disorders: Insights from a Swedish Nationwide Study https://news.medxy.ai/ja/accelerated-ttms-depression/Medxy AIja2026-08-10T18:35:47-07:00うつ病に対する加速型経頭蓋磁気刺激：機能的結合ベース標的と頭皮ベース標的の比較無作為化臨床試験 https://news.medxy.ai/vi/atms-depression-location/Medxy AIvi2026-08-10T18:35:29-07:00Định vị aTMS cho trầm cảm: dựa trên kết nối chức năng hay mốc da đầu? Một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/connectivity-vs-scalp-based-targeting-of-accelerated-transcranial-magnetic-stimulation-for-depression-a-randomized-clinical-trial/Medxy AIen2026-08-10T18:34:41-07:00Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial https://news.medxy.ai/zh/medicare-icu-telemedicine/Medxy AIzh2026-08-10T18:33:30-07:00住院 Medicare 按服务收费受益人远程医疗重症监护计费：2018—2024 年的趋势、影响因素及启示 https://news.medxy.ai/ja/telemedicine-icsu-trends/Medxy AIja2026-08-10T18:33:14-07:00入院Medicare受給者における遠隔医療集中治療の請求動向：2018年から2024年までの推移・規定因子・示唆 https://news.medxy.ai/vi/remote-medicare-care/Medxy AIvi2026-08-10T18:32:54-07:00Thanh toán chăm sóc tích cực từ xa ở người bệnh Medicare nội trú thanh toán theo dịch vụ: Xu hướng, yếu tố liên quan và hàm ý giai đoạn 2018–2024 https://news.medxy.ai/telemedicine-critical-care-billing-among-hospitalized-medicare-fee-for-service-beneficiaries-trends-determinants-and-implications-from-2018-to-2024/Medxy AIen2026-08-10T18:31:30-07:00Telemedicine Critical Care Billing Among Hospitalized Medicare Fee-For-Service Beneficiaries: Trends, Determinants, and Implications from 2018 to 2024 https://news.medxy.ai/zh/postoperative-delirium-impact/Medxy AIzh2026-08-10T18:30:12-07:00术后谵妄与再住院、认知下降之间的关系：老年患者研究解析 https://news.medxy.ai/ja/postoperative-delirium-cognitive-decline/Medxy AIja2026-08-10T18:29:55-07:00術後せん妄はなぜ認知機能低下につながるのか――再入院との関連を検証 https://news.medxy.ai/vi/postoperative-delirium-elderly/Medxy AIvi2026-08-10T18:29:39-07:00Giải mã mối liên hệ giữa rối loạn tri giác sau phẫu thuật, tái nhập viện và suy giảm nhận thức ở người cao tuổi https://news.medxy.ai/deciphering-the-link-between-postoperative-delirium-rehospitalization-and-cognitive-decline-in-older-adults/Medxy AIen2026-08-10T18:28:42-07:00Deciphering the Link Between Postoperative Delirium, Rehospitalization, and Cognitive Decline in Older Adults https://news.medxy.ai/zh/economic-impact-measles-2025/Medxy AIzh2026-08-10T18:27:31-07:002025年新墨西哥州麻疹暴发的经济影响：凸显预防未来暴发的成本 https://news.medxy.ai/economic-impact-of-the-2025-new-mexico-measles-outbreak-highlighting-the-cost-of-efforts-to-prevent-future-outbreaks/Medxy AIen2026-08-10T18:25:44-07:00Economic Impact of the 2025 New Mexico Measles Outbreak: Highlighting the Cost of Efforts to Prevent Future Outbreaks https://news.medxy.ai/zh/haploidentical-transplant-preconditioning/Medxy AIzh2026-08-10T18:24:20-07:00单倍型相合移植中全身照射与化疗预处理之比较：EBMT登记研究对首次缓解期AML患者的启示 https://news.medxy.ai/ja/aml-transplant-comparison/Medxy AIja2026-08-10T18:24:01-07:00初回寛解期AMLに対する半合致移植における全身放射線照射と化学療法前処置の比較：EBMTレジストリからの知見 https://news.medxy.ai/vi/total-body-irradiation-vs-conditioning-aml/Medxy AIvi2026-08-10T18:23:40-07:00So sánh chiếu xạ toàn thân và điều kiện hóa hóa trị trong ghép nửa hòa hợp cho bệnh nhân AML ở lần lui bệnh đầu tiên: Dữ liệu từ sổ đăng ký EBMT https://news.medxy.ai/comparing-total-body-irradiation-and-chemotherapy-conditioning-in-haploidentical-transplants-for-aml-patients-in-first-remission-insights-from-the-ebmt-registry/Medxy AIen2026-08-10T18:22:18-07:00Comparing Total Body Irradiation and Chemotherapy Conditioning in Haploidentical Transplants for AML Patients in First Remission: Insights from the EBMT Registry https://news.medxy.ai/zh/pembrolizumab-radiotherapy-potential/Medxy AIzh2026-08-10T18:21:01-07:00帕博利珠单抗联合放疗在晚期皮肤 T 细胞淋巴瘤中展现潜力：英国 NCRI Ⅱ期试验最终结果 https://news.medxy.ai/ja/pembrolizumab-radiation-skin-lymphoma/Medxy AIja2026-08-10T18:20:46-07:00進行皮膚T細胞リンパ腫におけるpembrolizumab併用放射線療法の可能性：英国NCRI第II相試験の最終結果 https://news.medxy.ai/vi/pembrolizumab-radiation-lymphoma/Medxy AIvi2026-08-10T18:20:26-07:00Pembrolizumab phối hợp xạ trị cho thấy triển vọng trong u lympho tế bào T ở da tiến xa: Kết quả cuối cùng từ thử nghiệm giai đoạn II UK NCRI https://news.medxy.ai/pembrolizumab-combined-with-radiotherapy-shows-promise-in-advanced-cutaneous-t-cell-lymphoma-final-results-from-uk-ncri-phase-ii-trial/Medxy AIen2026-08-10T18:19:05-07:00Pembrolizumab Combined with Radiotherapy Shows Promise in Advanced Cutaneous T-Cell Lymphoma: Final Results from UK NCRI Phase II Trial https://news.medxy.ai/zh/atelis-syndrome-causes/Medxy AIzh2026-08-10T18:16:31-07:00揭示Atelis Syndrome的病因：SLF2与SMC5功能异常驱动造血干细胞老化及骨髓增生异常综合征易感性 https://news.medxy.ai/ja/atelis-syndrome-overview/Medxy AIja2026-08-10T18:16:12-07:00Atelis症候群の全貌：SLF2・SMC5異常が引き起こす造血幹細胞老化と骨髄異形成症候群素因 https://news.medxy.ai/vi/slf2-and-smc5-dysfunction-as-drivers-of-hematopoietic-stem-cell-aging-and-myelodysplastic-syndrome-predisposition/Medxy AIvi2026-08-10T18:15:53-07:00Hội chứng Atelis: Rối loạn chức năng SLF2 và SMC5 là tác nhân thúc đẩy quá trình lão hóa tế bào gốc tạo máu và nguy cơ mắc hội chứng rối loạn sinh tủy https://news.medxy.ai/unveiling-atelis-syndrome-slf2-and-smc5-dysfunction-as-drivers-of-hematopoietic-stem-cell-aging-and-myelodysplastic-syndrome-predisposition/Medxy AIen2026-08-10T18:14:57-07:00Unveiling Atelis Syndrome: SLF2 and SMC5 Dysfunction as Drivers of Hematopoietic Stem Cell Aging and Myelodysplastic Syndrome Predisposition https://news.medxy.ai/zh/raas-inhibitors-sickle-cell-anemia/Medxy AIzh2026-08-10T18:13:35-07:00RAAS 抑制剂会加重镰状细胞病贫血：临床与机制新认识 https://news.medxy.ai/ja/sickle-cell-raas-inhibitors/Medxy AIja2026-08-10T18:13:15-07:00鎌状赤血球病におけるRAAS阻害薬は貧血を悪化させる：臨床的・機序的考察 https://news.medxy.ai/vi/renin-angiotensin-inhibitors-sickle-cell/Medxy AIvi2026-08-10T18:12:55-07:00Thuốc ức chế hệ renin-angiotensin-aldosterone làm nặng thiếu máu trong bệnh hồng cầu hình liềm: Những hiểu biết lâm sàng và cơ chế https://news.medxy.ai/renin-angiotensin-aldosterone-system-inhibitors-worsen-anemia-in-sickle-cell-disease-clinical-and-mechanistic-insights/Medxy AIen2026-08-10T18:11:48-07:00Renin-Angiotensin-Aldosterone System Inhibitors Worsen Anemia in Sickle Cell Disease: Clinical and Mechanistic Insights https://news.medxy.ai/ultrasound-guided-brachiocephalic-venipuncture-for-neonatal-central-venous-access-a-multicenter-study-validating-safety-and-feasibility/Medxy AIen2026-08-10T18:09:35-07:00Ultrasound-Guided Brachiocephalic Venipuncture for Neonatal Central Venous Access: A Multicenter Study Validating Safety and Feasibility https://news.medxy.ai/zh/texas-abortion-impact/Medxy AIzh2026-08-10T18:08:15-07:00德州堕胎禁令对住院孕妇重症结局的影响：一项回顾性队列分析 https://news.medxy.ai/ja/texas-abortion-impact-2/Medxy AIja2026-08-10T18:07:57-07:00テキサス州の中絶禁止は入院妊婦の重篤疾患にどう影響したか：後ろ向きコホート解析 https://news.medxy.ai/vi/texas-abortion-ban-impact/Medxy AIvi2026-08-10T18:07:34-07:00Tác động của lệnh cấm phá thai tại Texas đối với bệnh nặng nguy kịch ở phụ nữ mang thai nhập viện: Phân tích đoàn hệ hồi cứu https://news.medxy.ai/impact-of-texas-abortion-ban-on-critical-illness-in-hospitalized-pregnant-women-a-retrospective-cohort-analysis/Medxy AIen2026-08-10T18:06:20-07:00Impact of Texas Abortion Ban on Critical Illness in Hospitalized Pregnant Women: A Retrospective Cohort Analysis https://news.medxy.ai/zh/lasik-iol-power-calculation/Medxy AIzh2026-08-10T13:58:09-07:00近视激光视力矫正后如何更准确地计算人工晶状体屈光力：基于14种公式并纳入后角膜曲率的多中心研究解析 https://news.medxy.ai/ja/iols-calculation-optimize/Medxy AIja2026-08-10T13:57:52-07:00近視レーザー視力矯正後のIOL度数計算を最適化する：後角膜曲率を考慮した14式の多施設評価から得られた知見 https://news.medxy.ai/vi/iol-power-optimization/Medxy AIvi2026-08-10T13:57:31-07:00Tối ưu hóa tính công suất IOL sau chỉnh thị lực bằng laser do cận thị: Kết quả từ đánh giá đa trung tâm 14 công thức có xem xét độ cong giác mạc sau https://news.medxy.ai/optimizing-iol-power-calculation-after-myopic-laser-vision-correction-insights-from-a-multicenter-evaluation-of-14-formulas-with-posterior-corneal-curvature-consideration/Medxy AIen2026-08-10T13:56:43-07:00Optimizing IOL Power Calculation After Myopic Laser Vision Correction: Insights from a Multicenter Evaluation of 14 Formulas with Posterior Corneal Curvature Consideration https://news.medxy.ai/zh/identifying-risk-factors-for-progression-from-primary-angle-closure-suspect-to-primary-angle-closure/Medxy AIzh2026-08-10T13:49:04-07:00识别从原发性房角关闭可疑状态进展为原发性房角关闭的危险因素：来自 ANA-LIS 试验的启示 https://news.medxy.ai/ja/pacs-to-pac-risk-factors/Medxy AIja2026-08-10T13:48:46-07:00PACSからPACへの進行を左右する危険因子とは？ ANA-LIS試験が示した前眼部所見の重要性 https://news.medxy.ai/vi/from-pacs-to-pac/Medxy AIvi2026-08-10T13:48:27-07:00Từ PACS đến PAC: Những yếu tố nào báo trước tiến triển trong nghiên cứu ANA-LIS? https://news.medxy.ai/identifying-risk-factors-for-progression-from-primary-angle-closure-suspect-to-primary-angle-closure-insights-from-the-ana-lis-trial/Medxy AIen2026-08-10T13:47:40-07:00Identifying Risk Factors for Progression from Primary Angle Closure Suspect to Primary Angle Closure: Insights from the ANA-LIS Trial https://news.medxy.ai/zh/naion-risk-glp1/Medxy AIzh2026-08-10T13:42:40-07:00视盘拥挤与 GLP-1 受体激动剂使用者 NAION 风险分层：来自大型多中心研究的启示 https://news.medxy.ai/ja/glp-1-naion-risk/Medxy AIja2026-08-10T13:42:23-07:00GLP-1受容体作動薬使用者における視神経乳頭crowdingとNAIONリスク層別化：大規模多施設研究からの知見 https://news.medxy.ai/vi/glp1-naion-risk/Medxy AIvi2026-08-10T13:42:04-07:00Đĩa thị chật và phân tầng nguy cơ NAION ở người dùng chất chủ vận thụ thể GLP-1: phát hiện từ một nghiên cứu đa trung tâm quy mô lớn https://news.medxy.ai/crowded-optic-discs-and-risk-stratification-of-naion-in-glp-1-receptor-agonist-users-insights-from-a-large-multicenter-study/Medxy AIen2026-08-10T13:41:11-07:00Crowded Optic Discs and Risk Stratification of NAION in GLP-1 Receptor Agonist Users: Insights from a Large Multicenter Study https://news.medxy.ai/zh/team-behavior-and-patient-outcome-following-factors-training-in-pediatric-airway-endoscopy/Medxy AIzh2026-08-09T11:24:59-07:00儿科气道内镜检查中人因培训后的团队行为与患者预后变化 https://news.medxy.ai/ja/team-behavior-and-patient-outcome-following-human-factors-training-in-pediatric-airway-endoscopy/Medxy AIja2026-08-09T11:24:40-07:00小児の気道管理場面におけるヒューマンファクターズ・プログラム導入後のチーム行動および患者転帰の変化 https://news.medxy.ai/vi/team-behavior-and-patient-outcome-changes-following-human-factors-training-in-pediatric-airway-endoscopy/Medxy AIvi2026-08-09T11:24:19-07:00Những thay đổi về hành vi của ê-kíp và kết quả điều trị của bệnh nhân sau khi triển khai chương trình về yếu tố con người trong bối cảnh xử trí đường thở nhi khoa https://news.medxy.ai/team-behavior-and-patient-outcome-changes-following-human-factors-training-in-pediatric-airway-endoscopy-a-review-of-evidence-and-clinical-implications/Medxy AIen2026-08-09T11:23:33-07:00Team Behavior and Patient Outcome Changes Following Human Factors Training in Pediatric Airway Endoscopy: A Review of Evidence and Clinical Implications https://news.medxy.ai/zh/voice-changes-testosterone/Medxy AIzh2026-08-09T11:07:42-07:00跨男性青少年与年轻成人睾酮治疗中的嗓音纵向变化：一项前瞻性队列研究的启示 https://news.medxy.ai/ja/transmasculine-puberty-testosterone/Medxy AIja2026-08-09T11:07:24-07:00トランスマスキュリンの思春期・若年成人におけるテストステロン療法と声の経時的変化：前向きコホート研究からの知見 https://news.medxy.ai/vi/voice-changes-transgender-teens/Medxy AIvi2026-08-09T11:07:06-07:00Biến đổi giọng nói theo thời gian ở thanh thiếu niên và người trẻ chuyển nam điều trị testosterone: Phát hiện từ một nghiên cứu thuần tập tiền cứu https://news.medxy.ai/longitudinal-voice-changes-in-transmasculine-adolescents-and-young-adults-undergoing-testosterone-therapy-insights-from-a-prospective-cohort-study/Medxy AIen2026-08-09T11:06:18-07:00Longitudinal Voice Changes in Transmasculine Adolescents and Young Adults Undergoing Testosterone Therapy: Insights from a Prospective Cohort Study https://news.medxy.ai/zh/early-discharge-cabg/Medxy AIzh2026-08-09T11:01:51-07:00单纯冠状动脉旁路移植术后提前出院：对住院时长与患者结局的影响 https://news.medxy.ai/ja/early-discharge-effects/Medxy AIja2026-08-09T11:01:37-07:00孤立性CABG後の早期退院がもたらす効果：入院期間と患者転帰への影響 https://news.medxy.ai/vi/early-discharge-after-bypass/Medxy AIvi2026-08-09T11:01:21-07:00Xuất viện sớm sau phẫu thuật bắc cầu động mạch vành đơn thuần: tác động lên thời gian nằm viện và kết cục người bệnh https://news.medxy.ai/expedited-discharge-after-isolated-coronary-artery-bypass-grafting-impacts-on-hospital-stay-and-patient-outcomes/Medxy AIen2026-08-09T11:00:46-07:00Expedited Discharge After Isolated Coronary Artery Bypass Grafting: Impacts on Hospital Stay and Patient Outcomes https://news.medxy.ai/zh/gastric-cancer-genomics/Medxy AIzh2026-08-09T11:00:10-07:00原发胃癌的基因组特征可预测复发模式与生存结局 https://news.medxy.ai/ja/genomic-analysis-cancer/Medxy AIja2026-08-09T10:59:54-07:00原発胃腫瘍のゲノム解析が再発様式と生存予後を予測する https://news.medxy.ai/vi/stomach-tumor-genome/Medxy AIvi2026-08-09T10:59:37-07:00Giải trình tự bộ gen khối u dạ dày nguyên phát giúp dự đoán kiểu tái phát và tiên lượng sống còn https://news.medxy.ai/genomic-profiling-of-primary-gastric-tumors-predicts-recurrence-patterns-and-survival-outcomes/Medxy AIen2026-08-09T10:58:44-07:00Genomic Profiling of Primary Gastric Tumors Predicts Recurrence Patterns and Survival Outcomes https://news.medxy.ai/zh/robotic-liver-transplant/Medxy AIzh2026-08-09T10:57:38-07:00机器人全肝移植新进展：45例病例与基准结局分析 https://news.medxy.ai/ja/robot-assisted-liver-transplant/Medxy AIja2026-08-09T10:57:22-07:00ロボット支援全肝移植：45例から見えた知見とベンチマーク成績の検証 https://news.medxy.ai/vi/robotic-liver-transplant-2/Medxy AIvi2026-08-09T10:57:04-07:00Ghép gan toàn bộ bằng robot: Kết quả từ 45 ca và phân tích benchmark https://news.medxy.ai/robotic-whole-graft-liver-transplantation-insights-from-45-cases-and-benchmark-outcome-analysis/Medxy AIen2026-08-09T10:56:28-07:00Robotic Whole-Graft Liver Transplantation: Insights from 45 Cases and Benchmark Outcome Analysis https://news.medxy.ai/zh/gynecological-cancer-trial-challenges/Medxy AIzh2026-08-09T10:54:46-07:00妇科癌症临床试验为何难以收官：未完成的关键原因与改进策略 https://news.medxy.ai/ja/gynecologic-cancer-trials/Medxy AIja2026-08-09T10:54:32-07:00婦人科がん臨床試験はなぜ完遂が難しいのか：不完遂の要因と改善策を探る https://news.medxy.ai/vi/gynecological-cancer-trials/Medxy AIvi2026-08-09T10:54:14-07:00Thử nghiệm ung thư phụ khoa vì sao hay dang dở? Các yếu tố then chốt và hướng cải thiện https://news.medxy.ai/navigating-challenges-in-gynecologic-cancer-trials-key-factors-behind-non-completion-and-strategies-for-improvement/Medxy AIen2026-08-09T10:53:38-07:00Navigating Challenges in Gynecologic Cancer Trials: Key Factors Behind Non-Completion and Strategies for Improvement https://news.medxy.ai/zh/postpartum-ovarian-failure-risk/Medxy AIzh2026-08-09T10:50:02-07:00重度产后出血并需输血者早发性卵巢功能不全风险升高：来自韩国全国队列的研究见解 https://news.medxy.ai/ja/early-ovarian-failure-risk/Medxy AIja2026-08-09T10:49:48-07:00輸血を要する重症産後出血後に高まる早発卵巣不全リスク――韓国全国コホート研究からの知見 https://news.medxy.ai/vi/postpartum-hemorrhage-risk/Medxy AIvi2026-08-09T10:49:31-07:00Xuất huyết sau sinh nặng phải truyền máu làm tăng nguy cơ suy buồng trứng sớm: Dữ liệu từ một đoàn hệ toàn quốc tại Hàn Quốc https://news.medxy.ai/elevated-risk-of-premature-ovarian-failure-following-severe-postpartum-hemorrhage-requiring-blood-transfusion-insights-from-a-nationwide-korean-cohort/Medxy AIen2026-08-09T10:48:47-07:00Elevated Risk of Premature Ovarian Failure Following Severe Postpartum Hemorrhage Requiring Blood Transfusion: Insights from a Nationwide Korean Cohort https://news.medxy.ai/zh/late-pregnancy-doppler/Medxy AIzh2026-08-09T10:47:31-07:00读懂妊娠晚期子宫动脉多普勒：子痫前期中胎盘与血管病理生理的联系 https://news.medxy.ai/ja/late-pregnancy-uterine-artery-doppler/Medxy AIja2026-08-09T10:47:14-07:00妊娠後期の子宮動脈ドプラ所見を読み解く：子癇前症における胎盤病態と血管病態の関連 https://news.medxy.ai/vi/doppler-placenta-preeclampsia/Medxy AIvi2026-08-09T10:46:53-07:00Giải mã kết quả Doppler động mạch tử cung ở cuối thai kỳ: liên hệ giữa bệnh lý nhau thai và mạch máu trong tiền sản giật https://news.medxy.ai/deciphering-uterine-artery-doppler-findings-in-late-pregnancy-linking-placental-and-vascular-pathophysiology-in-preeclampsia/Medxy AIen2026-08-09T10:45:49-07:00Deciphering Uterine Artery Doppler Findings in Late Pregnancy: Linking Placental and Vascular Pathophysiology in Preeclampsia https://news.medxy.ai/zh/integrative-menopause-care/Medxy AIzh2026-08-09T10:43:25-07:00绝经期整合医学：基于证据的非激素症状管理策略 https://news.medxy.ai/ja/integrative-medicine-approaches-for-menopause-evidence/Medxy AIja2026-08-09T10:43:11-07:00更年期に対する統合医療的アプローチ https://news.medxy.ai/vi/menopause-hormone-free-strategies/Medxy AIvi2026-08-09T10:42:54-07:00Mãn kinh: Các chiến lược không dùng hormone dựa trên bằng chứng trong y học tích hợp https://news.medxy.ai/integrative-medicine-approaches-for-menopause-evidence-based-nonhormonal-strategies-for-symptom-management/Medxy AIen2026-08-09T10:42:03-07:00Integrative Medicine Approaches for Menopause: Evidence-Based Nonhormonal Strategies for Symptom Management https://news.medxy.ai/ja/beacon-hcc-treatment/Medxy AIja2026-08-09T10:39:26-07:00BEACON-HCC：肝細胞癌の治療割り当てを再構築する北米コンセンサス https://news.medxy.ai/vi/beacon-hcc-liver-cancer/Medxy AIvi2026-08-09T10:38:56-07:00BEACON-HCC: Đồng thuận Bắc Mỹ tái định hình phân bổ điều trị ung thư biểu mô tế bào gan https://news.medxy.ai/zh/beacon-hcc-consensus/Medxy AIzh2026-08-09T10:38:29-07:00BEACON-HCC：重塑肝细胞癌治疗分配的北美共识 https://news.medxy.ai/beacon-hcc-a-north-american-consensus-reshaping-treatment-allocation-for-hepatocellular-carcinoma/Medxy AIen2026-08-09T10:37:01-07:00BEACON-HCC: A North American consensus reshaping treatment allocation for hepatocellular carcinoma https://news.medxy.ai/zh/exosome-liquid-biopsy/Medxy AIzh2026-08-09T10:35:56-07:00循环外泌体液体活检标志物：预测肝细胞癌免疫检查点治疗耐药的新线索 https://news.medxy.ai/ja/liquid-biopsy-hcc/Medxy AIja2026-08-09T10:35:40-07:00肝細胞癌における免疫療法抵抗性を予測するリキッドバイオプシーとしての細胞外小胞 https://news.medxy.ai/vi/exosome-liquid-biopsy-2/Medxy AIvi2026-08-09T10:35:22-07:00Túi ngoại bào trong sinh thiết lỏng: dấu ấn dự đoán kháng trị với liệu pháp điểm kiểm soát miễn dịch ở ung thư biểu mô tế bào gan https://news.medxy.ai/extracellular-vesicles-as-liquid-biopsy-biomarkers-predicting-immune-checkpoint-therapy-resistance-in-hepatocellular-carcinoma/Medxy AIen2026-08-09T10:34:41-07:00Extracellular Vesicles as Liquid Biopsy Biomarkers Predicting Immune Checkpoint Therapy Resistance in Hepatocellular Carcinoma https://news.medxy.ai/zh/low-dose-colchicine-prevention/Medxy AIzh2026-08-09T09:46:58-07:00低剂量秋水仙碱能否预防急性脑内出血后的血管事件？一项安慰剂对照先导试验的启示 https://news.medxy.ai/ja/colchicine-acute-brain-bleed/Medxy AIja2026-08-09T09:46:43-07:00急性脳内出血後の血管イベント予防における低用量コルヒチンの評価：プラセボ対照パイロット試験からの知見 https://news.medxy.ai/vi/low-dose-colchicine-bleeding/Medxy AIvi2026-08-09T09:46:25-07:00Colchicine liều thấp sau xuất huyết nội não cấp: tín hiệu khả thi từ một thử nghiệm thí điểm có đối chứng giả dược https://news.medxy.ai/evaluating-low-dose-colchicine-for-preventing-vascular-events-after-acute-intracerebral-hemorrhage-insights-from-a-placebo-controlled-pilot-trial/Medxy AIen2026-08-09T09:45:14-07:00Evaluating Low-Dose Colchicine for Preventing Vascular Events After Acute Intracerebral Hemorrhage: Insights from a Placebo-Controlled Pilot Trial https://news.medxy.ai/zh/diverse-readmission-profiles-after-chronic-subdural-hematoma/Medxy AIzh2026-08-09T09:35:47-07:00基于机器学习的慢性硬膜下血肿住院患者再入院特征分析 https://news.medxy.ai/ja/readmission-profiles-after-chronic-subdural-hematoma/Medxy AIja2026-08-09T09:35:30-07:00慢性硬膜下血腫による入院後の再入院に関する機械学習を用いた特性解析 https://news.medxy.ai/vi/recurrent-chronic-subdural-hematoma/Medxy AIvi2026-08-09T09:34:55-07:00Tái nhập viện sau tụ máu dưới màng cứng mạn tính: Góc nhìn từ phân kiểu hình bằng học máy https://news.medxy.ai/diverse-readmission-profiles-after-chronic-subdural-hematoma-insights-from-machine-learning-phenotyping/Medxy AIen2026-08-09T09:33:05-07:00Diverse Readmission Profiles After Chronic Subdural Hematoma: Insights from Machine Learning Phenotyping https://news.medxy.ai/zh/tavapadon-parkinsons-benefits/Medxy AIzh2026-08-09T09:31:06-07:00早期帕金森病中的 tavapadon：3 期试验显示运动获益与安全性前景 https://news.medxy.ai/ja/tavapadon-in-early-parkinsons-disease-promising-phase-3-trial/Medxy AIja2026-08-09T09:30:45-07:00パーキンソン病に対する用量調節可能なタバパドンの安全性、忍容性、および有効性（TEMPO-2）：第3相無作為化プラセボ対照二重盲検試験 https://news.medxy.ai/vi/tavapadon-parkinson/Medxy AIvi2026-08-09T09:30:22-07:00Tavapadon trong bệnh Parkinson giai đoạn sớm: thử nghiệm giai đoạn 3 cho thấy tín hiệu tích cực về an toàn và cải thiện triệu chứng vận động https://news.medxy.ai/tavapadon-in-early-parkinsons-disease-promising-phase-3-trial-highlights-safety-and-motor-symptom-benefits/Medxy AIen2026-08-09T09:28:31-07:00Tavapadon in Early Parkinson’s Disease: Promising Phase 3 Trial Highlights Safety and Motor Symptom Benefits https://news.medxy.ai/zh/men2-children-thyroid-surgery/Medxy AIzh2026-08-09T09:27:33-07:00权衡获益与风险：儿童 MEN2 患者预防性甲状腺切除术结局 https://news.medxy.ai/ja/risk-benefit-balance-2/Medxy AIja2026-08-09T09:27:13-07:00利益とリスクの均衡を探る：小児MEN2患者における予防的甲状腺摘出術の転帰 https://news.medxy.ai/vi/preventive-thyroidectomy-men2/Medxy AIvi2026-08-09T09:26:49-07:00Cắt tuyến giáp dự phòng ở trẻ mắc MEN2: lợi ích ung thư học và nguy cơ phẫu thuật cần được cân bằng https://news.medxy.ai/balancing-benefits-and-risks-prophylactic-thyroidectomy-outcomes-in-pediatric-men2-patients/Medxy AIen2026-08-09T09:25:08-07:00Balancing Benefits and Risks: Prophylactic Thyroidectomy Outcomes in Pediatric MEN2 Patients https://news.medxy.ai/zh/endometriosis-diabetes-risk-2/Medxy AIzh2026-08-08T23:40:40-07:00子宫内膜异位症不同亚型与2型糖尿病风险升高：ARCHES研究带来的启示 https://news.medxy.ai/ja/endometriosis-diabetes-risk/Medxy AIja2026-08-08T23:40:23-07:00子宮内膜症の病型別にみる2型糖尿病リスク上昇：ARCHES研究からの示唆 https://news.medxy.ai/vi/endometriosis-subtypes-diabetes-risk/Medxy AIvi2026-08-08T23:40:02-07:00Các phân nhóm lạc nội mạc tử cung và nguy cơ đái tháo đường type 2: phát hiện nổi bật từ nghiên cứu ARCHES https://news.medxy.ai/linking-endometriosis-subtypes-to-increased-risk-of-type-2-diabetes-insights-from-the-arches-study/Medxy AIen2026-08-08T23:37:43-07:00Linking Endometriosis Subtypes to Increased Risk of Type 2 Diabetes: Insights from the ARCHES Study https://news.medxy.ai/ersodetug-for-refractory-hypoglycemia-due-to-malignant-insulin-secreting-tumors-a-compassionate-use-case-series/Medxy AIen2026-08-08T23:33:45-07:00Ersodetug for Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors: A Compassionate Use Case Series